Healthcare Sales & Marketing Network News: FLASH

Searching News Database: FLASH

HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory

HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 13 Oct 2023
Prominent U.S. hospital expands RayStation installation for proton treatment planning
Devices Oncology

HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Devices Endocrinology Regulatory

HSMN NewsFeed - 20 Jul 2023
MediView Receives FDA 510(k) Clearance for XR90 Augmented Reality-Based Visualization and Navigation Platform
Devices Surgery FDA

HSMN NewsFeed - 10 Jul 2023
RayCare in clinical use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland
Devices Oncology

HSMN NewsFeed - 1 Jun 2023
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Devices Interventional Product Launch FDA

HSMN NewsFeed - 4 May 2023
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Feb 2023
Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte(TM) New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Feb 2023
Ostial Corp Closes $7.5M Series C Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 6 Sep 2022
First Randomized Controlled Study with RejuvenAir(R) for Chronic Bronchitis shows Clinically Significant Results
Devices Drug Delivery Interventional

HSMN NewsFeed - 18 Aug 2022
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Feb 2022
Lumify Care Joins Forces with Medline to Expand Access to its Wearable Illumination Product Nationwide
Devices Distribution

HSMN NewsFeed - 21 Jun 2021
RaySearch Signs Extensive Agreements With a Clinic in Switzerland Including an Order For RayCare and the First Order For RayIntelligence
Devices Oncology

HSMN NewsFeed - 19 Feb 2021
Astellas Announces Positive Topline Results from Two Phase 3 Pivotal Global Trials of Fezolinetant for the Nonhormonal Treatment of Vasomotor Symptoms in Postmenopausal Women
Biopharmaceuticals

HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 11 Nov 2020
CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
Devices

HSMN NewsFeed - 3 Nov 2020
FDA Approves Updated Label for Endari(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Oct 2020
CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
Devices

HSMN NewsFeed - 12 Oct 2020
Varian Receives Investigational Device Exemption (IDE) and Prepares for First Ever Clinical Trial of FLASH Therapy
Devices Oncology FDA

HSMN NewsFeed - 1 Sep 2020
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
Devices Monitoring Endocrinology Reimbursement

HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2020
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Sep 2019
Emmaus Life Sciences Reinforces Positive Outcomes of Endari(R) Clinical Trials, Including Efficacy Findings That Led to FDA Approval
Biopharmaceuticals

HSMN NewsFeed - 16 Sep 2019
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
Devices Oncology Product Launch

HSMN NewsFeed - 14 May 2019
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
Devices Oncology

HSMN NewsFeed - 9 May 2019
Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China
Devices Oncology

HSMN NewsFeed - 3 Apr 2019
CSA Medical, Inc. Receives FDA Breakthrough Device Designation and IDE Approval for its RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
Devices FDA

HSMN NewsFeed - 3 Apr 2019
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Devices Oncology

HSMN NewsFeed - 4 Feb 2019
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jan 2019
Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in Singapore
Devices Oncology

HSMN NewsFeed - 24 Oct 2018
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
Devices Diagnostics FDA Product Launch

HSMN NewsFeed - 23 Oct 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena(R) (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Oct 2018
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Oct 2018
CSA Medical Secures $23 Million to Advance its Cryospray(TM) Therapies for Esophageal Disease and COPD
Devices Venture Capital

HSMN NewsFeed - 14 Aug 2018
Inova Diagnostics Receives FDA Clearance for Test to Detect Antibodies to HMGCR
Diagnostics FDA

HSMN NewsFeed - 13 Aug 2018
7D Surgical Receives FDA Approval For Cranial Surgery
Devices Neurosurgery Surgery FDA

HSMN NewsFeed - 26 Jul 2018
Flashback Technologies Announces U.S. FDA Clearance For The CipherOx(R) CRI M1 Compensatory Reserve Index (CRI(TM)) Monitor To Accurately Detect And Trend Acute Blood Loss
Devices Monitoring FDA

HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 7 Feb 2018
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 6 Feb 2018
7D Surgical Completes Significant Round of Financing
Devices Surgery Venture Capital

HSMN NewsFeed - 6 Feb 2018
New Study Finds truFreeze(R) Spray Cryotherapy Less Painful than Radiofrequency Ablation for Treatment of Barrett's Esophagus Related Diseases
Devices Gastroenterology

HSMN NewsFeed - 3 Jan 2018
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
Diagnostics FDA

HSMN NewsFeed - 31 Aug 2017
CSA Medical Announces Expansion of truFreeze(R) Label to Include Barrett's Esophagus with Low Grade Dysplasia
Devices Interventional FDA

HSMN NewsFeed - 8 May 2017
Abbott Announces National Reimbursement for FreeStyle(R) Libre in France, Providing Access to Revolutionary Technology for People with Diabetes
Diagnostics Endocrinology Reimbursement

HSMN NewsFeed - 27 Apr 2017
Centurion's Family of Comprehensive Vascular Access Solutions Continues to Grow
Devices Product Launch

HSMN NewsFeed - 20 Apr 2017
7D Surgical Enters Into Key Distribution Agreements in the United States for Its Breakthrough Image Guidance System for Spine Surgery
Devices Orthopaedic Neurosurgery Distribution

HSMN NewsFeed - 3 Apr 2017
Astellas to Acquire Ogeda SA
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Jan 2017
Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 2 Dec 2016
CSA Medical Announces First Use of Significantly Reduced Diameter Cryogen Decompression Tube in a truFreeze(R) Spray Cryotherapy Case
Devices Product Launch

HSMN NewsFeed - 8 Sep 2016
CSA Medical Presented Early Clinical Data on the RejuvenAir Metered Cryospray System at the European Respiratory Society (ERS) Conference
Devices

HSMN NewsFeed - 28 Mar 2016
Easy and Effective Functional Test for Pediatric Ophthalmology Assessment with RETeval Complete(TM) Touted by Early Adopters
Devices Ophthalmology

HSMN NewsFeed - 16 Feb 2016
Abbott Receives Approval in Australia for FreeStyle(R) Libre--the Revolutionary Glucose Monitoring System for People with Diabetes
Devices Endocrinology Monitoring Regulatory

HSMN NewsFeed - 28 Aug 2015
Symmetry Surgical Acquires Vesocclude Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 12 Mar 2014
Symmetry Surgical Unveils Bookwalter(R) Femoral Elevator
Devices Orthopaedic Product Launch

HSMN NewsFeed - 19 Feb 2014
Parametric Sound Receives FDA Clearance for HyperSound
Devices FDA

HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Oct 2013
Neurotrope, Inc., Announces Hiring Robert Weinstein As Executive Vice President and Chief Financial Officer
Biopharmaceuticals Diagnostics Neurology Personnel

HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2013
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent(TM) in Routine Practice
Devices Interventional Cardiology

HSMN NewsFeed - 30 Apr 2013
Kevin M. Smith Appointed to Zynex Board of Directors
Devices Neurology Personnel

HSMN NewsFeed - 4 Mar 2013
Symmetry Surgical Unveils Next Generation Bookwalter(R) Self-Retaining Rotilt Ratchet
Devices Surgery

HSMN NewsFeed - 27 Feb 2013
Symmetry Surgical Continues European Presence With Distributor in the United Kingdom
Devices Surgery Distribution

HSMN NewsFeed - 16 Oct 2012
Symmetry Surgical Continues Global Expansion Through New Distributor Partnership With AMT Electrosurgery Inc. in Canada
Devices Surgery Distribution

HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2012
Symmetry Medical Announces FDA Clearance of Its FLASH PAK(R) Evolution Valve
Devices FDA

HSMN NewsFeed - 26 Jul 2012
Retractable Technologies, Inc. Launches New VanishPoint(R) Blood Collection Set
Devices

HSMN NewsFeed - 25 Jun 2012
Symmetry Medical Launches Complementary Additions to Its Micro Instrument Portfolio
Devices Neurosurgery

HSMN NewsFeed - 23 Mar 2012
Symmetry Medical Launches Enhancements to the BOOKWALTER(R) Surgical Retractor System
Devices Surgery

HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel™
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Dec 2011
Symmetry Medical to Acquire the Surgical Instruments Business of Codman & Shurtleff
Devices Acquisitions

HSMN NewsFeed - 6 Dec 2011
Tribogenics Raises $2.5 Million to Transform X-Ray Industry
Devices Radiology Venture Capital Personnel

HSMN NewsFeed - 14 Oct 2011
Health Discovery Corporation Agrees with the U.S. Preventive Services Task Force’s Position Against PSA-Based Screening for Prostate Cancer and Believes Its Four-Gene Assay for Prostate Cancer is the Best Alternative to PSA
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 12 Sep 2011
CSA Medical Appoints Wendelin Maners VP of Emerging Therapies
Devices Personnel

HSMN NewsFeed - 27 Aug 2011
U.S. Food And Drug Administration Approves Pfizer’s XALKORI(R) (crizotinib) As First And Only Therapy Specifically For Patients With Locally Advanced Or Metastatic ALK-Positive Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jul 2011
CSA Medical Completes $12.6 Million Series A Financing With Additional Venture Investment From Blue Heron Capital
Devices Venture Capital

HSMN NewsFeed - 20 Jun 2011
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer
Biopharmaceuticals Drug Delivery Oncology FDA

HSMN NewsFeed - 1 Feb 2011
Roger Hungerford Joins Board of Access Scientific
Devices Personnel

HSMN NewsFeed - 10 Nov 2010
FDA Approves Bionovo's Clinical Development Plan for Menerba
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Sep 2010
FDA Approves New Dosing for FASLODEX(R) (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Aug 2010
Bionovo Adds Dr. James H. Pickar, Former Executive at Wyeth, to Medical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jul 2010
ZOLL Propaq MD Monitor/Defibrillator Granted 510(k) Clearance by U.S. Food and Drug Administration
Devices Monitoring FDA

HSMN NewsFeed - 22 Jun 2010
DexCom Names Steven R. Pacelli Chief Operating Officer; Jorge Valdes Chief Technical Officer
Devices Monitoring Personnel

HSMN NewsFeed - 1 Jun 2010
GE Healthcare Unveils Innovative Technology in Breast Cancer Imaging; Can Reduce Time from Detection to Diagnosis
Devices Radiology

HSMN NewsFeed - 4 Mar 2010
Freedom Driver System Receives CE Mark to Power SynCardia's Total Artificial Heart in Europe
Devices Cardiology Regulatory

HSMN NewsFeed - 27 Jan 2010
The PICC WAND from Access Scientific Receives FDA Clearance
Devices FDA

HSMN NewsFeed - 4 Dec 2009
Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Nov 2009
Depomed Files Patent Infringement Lawsuit Against Lupin Limited
Biopharmaceuticals Generics Litigation FDA

HSMN NewsFeed - 18 Nov 2009
Depomed Promotes William Callahan to Vice President of Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2009
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 1 Sep 2009
Integrated Medical Systems Receives CE Mark for World's First 'Suitcase' Intensive Care Unit
Devices Monitoring Regulatory

HSMN NewsFeed - 19 Aug 2009
Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
Biopharmaceuticals Onology

HSMN NewsFeed - 4 Aug 2009
Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Jun 2009
Depomed Names Shay Weisbrich Vice President of Marketing
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 1 Jun 2009
FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 Apr 2009
Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Apr 2009
First Ever Prospective Fracture Study in Prostate Cancer Patients on ADT Reveals These Men Are at High Risk for Skeletal Fractures
Biopharmaceuticals Oncology Urology

HSMN NewsFeed - 22 Apr 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 9 Mar 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 9 Mar 2009
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Devices Urology Oncology

HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Feb 2009
Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 28 Jan 2009
Ipsen announces the signature of a co-promotion agreement with Novartis for Exforge in France
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2009
Bionovo Announces Cost Control Measures Taken
Biopharmaceuticals

HSMN NewsFeed - 5 Jan 2009
Depomed Announces Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2008
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Devices Urology

HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing

HSMN NewsFeed - 4 Dec 2008
Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc to Acquire U.S. Rights to Elestrin (TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 20 Nov 2008
Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Devices Urology

HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA

HSMN NewsFeed - 13 Oct 2008
Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit
Devices Monitoring FDA

HSMN NewsFeed - 7 Aug 2008
BioSante Pharmaceuticals Announces Reacquisition of Elestrin(TM), FDA Approved for Treatment of Hot Flashes
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 23 Jul 2008
Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory

HSMN NewsFeed - 9 Jul 2008
Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 16 Jun 2008
Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
Biopharmaceuticals

HSMN NewsFeed - 30 May 2008
NCCN Previews Chemotherapy Order Templates(TM)
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 May 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2008
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery

HSMN NewsFeed - 29 Apr 2008
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Apr 2008
Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System
Devices Endocrinology Distribution

HSMN NewsFeed - 16 Apr 2008
CoNCERT Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology

HSMN NewsFeed - 14 Apr 2008
Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
Devices Endocrinology

HSMN NewsFeed - 14 Apr 2008
KV Begins Shipping Evamist(TM) to Wholesalers
Biopharmaceuticals

HSMN NewsFeed - 24 Mar 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution

HSMN NewsFeed - 13 Mar 2008
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
Devices FDA Endocrinology

HSMN NewsFeed - 12 Mar 2008
More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Mar 2008
Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Mar 2008
GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Feb 2008
Fujifilm Receives FDA Clearance for Unity SpeedSuite(TM)
Devices Radiology FDA

HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Feb 2008
SonoSite Brings S Revolution to Musculoskeletal Imaging
Devices

HSMN NewsFeed - 20 Feb 2008
Depomed Names Abid Rawn Vice President of Sales and Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2008
Noven Announces Changes to Board of Directors and Senior Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jan 2008
Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals FDA Endocrinology Drug Delivery

HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Dec 2007
Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008
Biopharmaceuticals

HSMN NewsFeed - 3 Dec 2007
Depomed Names Michael Sweeney Vice President of Product Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2007
Cardium and InnerCool Complete $5 Million Commercial Financing to Support Launch of New Product Lines
Devices

HSMN NewsFeed - 29 Oct 2007
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 29 Oct 2007
Gyrus ACMI Introduces the World's First Endoscope Protection System (EPS) Designed to Prevent Accidental Laser Damage
Devices

HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 15 Oct 2007
Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2007
Depomed Announces Retirement of Chief Financial Officer John F. Hamilton
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
Depomed Announces Reduction in Force
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2007
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 Sep 2007
ART Appoints DiCamillo to Senior-Level Position of Global Sales & Marketing VP for Preclinical Imaging with Mandate to Implement Direct Commercialisation Strategy for its Optix Imaging System
Devices Personnel

HSMN NewsFeed - 31 Aug 2007
WorldHeart Appoints David Pellone Chief Financial Officer
Devices Cardiology Personnel

HSMN NewsFeed - 27 Aug 2007
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Aug 2007
Noven Completes Acquisition of JDS Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 30 Jul 2007
VIVUS Receives FDA Approval of Evamist NDA
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 24 Jul 2007
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Jul 2007
Wyeth Receives Approvable Letter from FDA for PRISTIQ for the Treatment of Vasomotor Symptoms Associated with Menopause
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 12 Jul 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
Biopharmaceuticals

HSMN NewsFeed - 10 Jul 2007
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Jul 2007
Depomed Reacquires the Rights to ProQuin(R) XR
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 28 Jun 2007
Bionovo Appoints Tom Chesterman as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2007
New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Jun 2007
TomoTherapy Incorporated Partners with Lawrence Livermore National Laboratory to Develop Compact Proton Therapy System
Devices Oncology

HSMN NewsFeed - 13 Jun 2007
BioSante Pharmaceuticals Announces the Commercial Launch of Elestrin(TM)
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2007
Bradley Pharmaceuticals Announces Launch of Elestrin(TM)
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2007
Richard Juelis Joins Bionovo's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Biopharmaceuticals

HSMN NewsFeed - 5 Jun 2007
FDA Approves Divigel(R) (estradiol gel) 0.1 Percent for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 31 May 2007
Rob Frankenberg, Ph.D. Joins Bionovo as Vice President of Drug Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 May 2007
VIVUS Closes EvaMist Transaction with KV Pharmaceutical
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 8 May 2007
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Apr 2007
Wyeth Responds to Special Report Published in New England Journal of Medicine

HSMN NewsFeed - 16 Apr 2007
Abbott Announces FDA Clearance and Launch of New FreeStyle Lite(TM) Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 12 Apr 2007
SonoSite Announces Engineering Breakthrough in Image Resolution for MicroMaxx System
Devices Radiology

HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 30 Mar 2007
KV Pharmaceutical Company Acquires U.S. Rights to EvaMist(TM) - A Novel New Product for the Treatment of the Symptoms of Menopause
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 30 Mar 2007
VIVUS Agrees to Sell EvaMist Rights to KV Pharmaceutical
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology

HSMN NewsFeed - 12 Mar 2007
Depomed Files Investigational New Drug Application for Gabapentin GR for the Treatment of Postmenopausal Hot Flashes
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 12 Mar 2007
Schering-Plough to Acquire Organon BioSciences
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Feb 2007
GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Devices

HSMN NewsFeed - 2 Feb 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jan 2007
Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 28 Dec 2006
BioSante Pharmaceuticals Initiates Phase III Study of LibiGel(R) (transdermal testosterone gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 19 Dec 2006
Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2006
Antares Receives First FDA Approval of ATD(TM) Gel Platform
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2006
BioSante Pharmaceuticals Receives FDA Approval of Bio-E-Gel(R) (estradiol gel), to be Marketed as Elestrin(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2006
Data Presented Today Show ARIMIDEX(R) Combined With Herceptin(R) Extended Progression-Free Survival in Patients With Advanced HER-2-Positive and Hormone Receptor-Positive Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Dec 2006
VIVUS Announces FDA Acceptance of EvaMist(TM) NDA Submission
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Dec 2006
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Dec 2006
LUNESTA(R) Perimenopause-Menopause Study Published in Journal of Obstetrics and Gynecology
Biopharmaceuticals

HSMN NewsFeed - 26 Nov 2006
SonoSite Introduces Fourth Major Upgrade for the MicroMaxx System
Devices Radiology

HSMN NewsFeed - 8 Nov 2006
Bradley Pharmaceuticals Enters Into Agreement With BioSante Pharmaceuticals for Estradiol Transdermal Gel
Biopharmaceuticals

HSMN NewsFeed - 8 Nov 2006
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2006
Pipex Therapeutics Merges With Sheffield Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Oct 2006
PharmaNova Grants Exclusive U.S. License to Depomed for Extended Release Gabapentin Use in Hot Flashes
Biopharmaceuticals Licensing

HSMN NewsFeed - 18 Oct 2006
Depomed Obtains Exclusive License to Gabapentin Use in Hot Flashes
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 29 Sep 2006
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
Devices Diagnostics Endocrinology

HSMN NewsFeed - 13 Sep 2006
One in Three Parents Surveyed Unaware of Easy Ketone Test That May Help Prevent the Onset of Diabetic Ketoacidosis (DKA)
Diagnostics Endocrinology

HSMN NewsFeed - 7 Sep 2006
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 7 Sep 2006
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 26 Jun 2006
Wyeth Submits Two New Drug Applications for Women's Health Therapies
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2006
In a Phase III Lipid Interim Analysis, ACAPODENE Treatment Lowered Cholesterol and Raised HDL In Prostate Cancer Patients On Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 May 2006
St. Alexius Medical Center Installs World's First Symbia S SPECT System
Devices Radiology

HSMN NewsFeed - 8 May 2006
Wyeth Comments on New Report From The Nurses' Health Study Published Today in the Archives of Internal Medicine
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 May 2006
VIVUS Announces Positive Phase 3 Clinical Trial Results for Evamist(TM) - The First Transdermal Spray for the Treatment of Menopausal Symptoms
Biopharmaceuticals Drug Delivery

Return to NewsFeed

Additional items found! 157

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 157 additional stories matching:
FLASH
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.